Day: February 9, 2015

Myriad Settles BRCA Patent Case with Quest; Only GeneDx Lawsuit Remains Feb. 9, 2015 NEW YORK (GenomeWeb) – Quest Diagnostics and Myriad Genetics have settled their patent dispute related to BRCA testing. Myriad along with its co-patent holders and Quest… Continue Reading →

(Reuters) – Achillion Pharmaceuticals Inc said its experimental hepatitis C drug, when used in combination with Gilead Sciences Inc’s Sovaldi, eradicated signs of the virus after six weeks of therapy, sending its shares up before the opening bell. If the… Continue Reading →